Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
IRL-201104 by Revolo Biotherapeutics for Eosinophilic Esophagitis: Likelihood of Approval
IRL-201104 is under clinical development by Revolo Biotherapeutics and currently in Phase II for Eosinophilic Esophagitis. According to GlobalData, Phase...
IRL-201104 by Revolo Biotherapeutics for Allergies: Likelihood of Approval
IRL-201104 is under clinical development by Revolo Biotherapeutics and currently in Phase II for Allergies. According to GlobalData, Phase II...
IRL-201104 by Revolo Biotherapeutics for Seasonal Allergic Rhinitis: Likelihood of Approval
IRL-201104 is under clinical development by Revolo Biotherapeutics and currently in Phase II for Seasonal Allergic Rhinitis. According to GlobalData,...
IRL-201104 by Revolo Biotherapeutics for Acute Respiratory Distress Syndrome: Likelihood of Approval
IRL-201104 is under clinical development by Revolo Biotherapeutics and currently in Phase I for Acute Respiratory Distress Syndrome. According to...
IRL-201104 by Revolo Biotherapeutics for Food Allergy: Likelihood of Approval
IRL-201104 is under clinical development by Revolo Biotherapeutics and currently in Phase I for Food Allergy. According to GlobalData, Phase...